奥浦迈: 奥浦迈：第二届董事会独立董事专门会议第四次会议决议

Core Points - The company held the fourth meeting of the second board of independent directors on August 21, 2025, via online communication, with all three independent directors present [1] - The meeting approved the adjustment of the estimated amount for certain daily related transactions for 2025, increasing the expected sales amount to Suzhou Haixing Biotechnology Co., Ltd. from 50,000 yuan to 1,000,000 yuan, and the expected purchase amount from NAPU Analysis Technology (Suzhou) Co., Ltd. from 300,000 yuan to 400,000 yuan [1] - The total estimated amount for daily related transactions for 2025 was adjusted from 4,460,000 yuan to 5,510,000 yuan, while other previously estimated amounts remained unchanged [1] Summary of Related Sections - The independent directors concluded that the adjustments to the estimated amounts for daily related transactions were necessary for the company's normal production and operations, reflecting business development and market demand changes [2] - The pricing policy for daily related transactions adheres to principles of openness, fairness, and justice, with transaction prices settled at market rates, ensuring no adverse impact on the company's financial status or operational results [2] - The adjustments do not create dependency on related parties and do not affect the company's business independence, with the proposal requiring further review by the company's board of directors [2]